| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.26 | 9e-15 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-10 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |